Papers
600 records — page 1 of 3
- The blockade of immune checkpoints in cancer immunotherapy article article
- Immunity, Inflammation, and Cancer article article
- Inflammation and cancer: back to Virchow? article article
- Cancer immunotherapy using checkpoint blockade article article
- On Spectral Clustering: Analysis and an algorithm article article
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion article article
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck article article
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade article article
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion article article
- STATs in cancer inflammation and immunity: a leading role for STAT3 article article
- Tumour-associated macrophages as treatment targets in oncology article article
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies article article
- Molecular mechanisms of T cell co-stimulation and co-inhibition article article
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial article article
- The mutational constraint spectrum quantified from variation in 141,456 humans article article
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa article article
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma article article
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer article article
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape article article
- TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells article article
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial article article
- Oncology Meets Immunology: The Cancer-Immunity Cycle article article
- Top 10 Challenges in Cancer Immunotherapy article article
- The Nature of Statistical Learning Theory article article
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients article article
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors article article
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial article article
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 article article
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma article article
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade article article
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy article article
- The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans article article
- Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells article article
- The B73 Maize Genome: Complexity, Diversity, and Dynamics article article
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma article article
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline article article
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer article article
- Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling article article
- GATEWAY™ vectors for Agrobacterium-mediated plant transformation article article
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. article article
- Structure and function of telomeres article article
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma article article
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer article article
- Learning Internal Representations by Error Propagation report report
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells article article
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma article article
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria article article
- Elements of cancer immunity and the cancer–immune set point article article
- An immunogenic personal neoantigen vaccine for patients with melanoma article article
- Neoantigens in cancer immunotherapy article article
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial article article
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma article article
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial article article
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial article article
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT book-chapter book-chapter
- Cancer immunotherapy comes of age article article
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma article article
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer article article
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy article article
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma article article
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma article article
- ANFIS: adaptive-network-based fuzzy inference system article article
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma article article
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy article article
- First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer article article
- The immune contexture in cancer prognosis and treatment article article
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review article article
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer article article
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer article article
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study article article
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma article article
- Neural networks for pattern recognition book-review book-review
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial article article
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic article article
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma article article
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer article article
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors article article
- Dendritic cells in cancer immunology and immunotherapy article article
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer article article
- Nonlinear Component Analysis as a Kernel Eigenvalue Problem article article
- Upstream and downstream of mTOR preprint preprint
- Direct Gene Transfer into Mouse Muscle in Vivo article article
- Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling article article
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethality article article
- A membrane-filter technique for the detection of complementary DNA article article
- Genome Sequence of the Nematode <i>C. elegans</i> : A Platform for Investigating Biology article article
- Nucleic acid detection with CRISPR-Cas13a/C2c2 article article
- TIMER2.0 for analysis of tumor-infiltrating immune cells article article
- Random decision forests conference-paper conference-paper
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes article article
- Evolutionary Rate at the Molecular Level article article
- Systematic functional analysis of the Caenorhabditis elegans genome using RNAi article article
- A global double‐fluorescent Cre reporter mouse article article
- Identification of the breast cancer susceptibility gene BRCA2 article article
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response article article
- Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy article article
- Probability, Random Variables, and Stochastic Processes. article article
- Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. article article
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences article article
- The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy article article
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up article article
- Pembrolizumab for Early Triple-Negative Breast Cancer article article
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial article article
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability article article
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study article article
- Intriguing properties of neural networks preprint preprint
- Learning to Forget: Continual Prediction with LSTM article article
- Deep Sparse Rectifier Neural Networks article article
- On combining classifiers article article
- Introduction to the theory of neural computation book-review book-review
- DNA targeting specificity of RNA-guided Cas9 nucleases article article
- Identification of Novel Genes Coding for Small Expressed RNAs article article
- Probability and Measure. article article
- Improving neural networks by preventing co-adaptation of feature detectors preprint preprint
- LIBLINEAR: A Library for Large Linear Classification article article
- Classification And Regression Trees book book
- Neural Networks And Learning Machines article article
- Pattern Recognition and Neural Networks book book
- Regression and time series model selection in small samples article article
- Approximation capabilities of multilayer feedforward networks article article
- “Neural” computation of decisions in optimization problems article article
- Mathematical Methods of Statistics. article article
- Modeling by shortest data description article article
- Advances in kernel methods: support vector learning other other
- Vision: A Computational Investigation into the Human Representation and Processing of Visual Information other other
- Extreme Learning Machine for Regression and Multiclass Classification article article
- ADADELTA: An Adaptive Learning Rate Method preprint preprint
- Mathematical Analysis of Random Noise article article
- Fundamentals of Recurrent Neural Network (RNN) and Long Short-Term Memory (LSTM) network article article
- A Review of Recurrent Neural Networks: LSTM Cells and Network Architectures article article
- Algorithms for Non-negative Matrix Factorization article article
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System article article
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector article article
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study article article
- Role for a bidentate ribonuclease in the initiation step of RNA interference article article
- Macrophage Diversity Enhances Tumor Progression and Metastasis article article
- Classification and Regression by randomForest article article
- Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review review review
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation article article
- The future of immune checkpoint therapy article article
- The Tumor Microenvironment Innately Modulates Cancer Progression article article
- TISIDB: an integrated repository portal for tumor–immune system interactions article article
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer article article
- How regulatory T cells work article article
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition article article
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial article article
- PD-1 and Its Ligands in Tolerance and Immunity article article
- A New Initiative on Precision Medicine article article
- Molecular and cellular insights into T cell exhaustion article article
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer article article
- Innate and adaptive immune cells in the tumor microenvironment article article
- T cell exclusion, immune privilege, and the tumor microenvironment article article
- A guide to cancer immunotherapy: from T cell basic science to clinical practice article article
- T cell exhaustion article article
- Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments article article
- Multiple significance tests: the Bonferroni method article article
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance article article
- Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing article article
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors article article
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity article article
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase article article
- Multiplex Genome Engineering Using CRISPR/Cas Systems article article
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans article article
- One-step inactivation of chromosomal genes in <i>Escherichia coli</i> K-12 using PCR products article article
- Macrophages as regulators of tumour immunity and immunotherapy article article
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 article article
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update article article
- Genome engineering using the CRISPR-Cas9 system article article
- PCR protocols — A guide to methods and applications article article
- Enzymatic assembly of DNA molecules up to several hundred kilobases article article
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells article article
- RNA-Guided Human Genome Engineering via Cas9 article article
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis review review
- Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade article article
- Loop-mediated isothermal amplification of DNA article article
- The new frontier of genome engineering with CRISPR-Cas9 article article
- Global quantification of mammalian gene expression control article article
- Green Fluorescent Protein as a Marker for Gene Expression article article
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy article article
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes article article
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex article article
- Cancer-related inflammation and treatment effectiveness article article
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i> article article
- Orthomyxoviridae: The Viruses and Their Replication. article article
- The random subspace method for constructing decision forests article article
- [1] Getting started with yeast book-chapter book-chapter
- CRISPR/Cas, the Immune System of Bacteria and Archaea article article
- FLS2 article article
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease article article
- Signal detection theory and psychophysics other other
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy article article
- Nasopharyngeal carcinoma article article
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients article article
- Cancer immunotherapy: moving beyond current vaccines article article
- The DNA-damage response in human biology and disease article article
- Development and Applications of CRISPR-Cas9 for Genome Engineering article article
- An Introduction to Support Vector Machines book book
- Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. article article
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering article article
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells article article